This site uses optional cookies which are currently not set, but will be if you visit another page. Find out more about the cookies we use

 
 

28Sep

2017 BioCap Conference

Location: Alderley Park Conference Centre, Cheshire


The sixth annual BioCap Conference, will bring together international investors, companies who are seeking finance and those who have a track record of raising finance. BioCap is the only specialist life science investment and showcase conference in the North of England and is aimed at highlighting the wealth of life science investment opportunities.

We are delighted that Dr Mene Pangalos, Executive Vice President - Innovative Medicines & Early Development Biotech Unit at AstraZeneca and Glenn Crocker, CEO at BioCity will giving the Keynote Addresses at the event.

Call For Pitches Competition
As part of the conference, we will continue to host the popular 'Company Pitching' competition and the submission of applications is now open.  Applications are invited from companies who are an established biomedical business and seeking or shortly starting to seek funding of £500k or above.

The 'Call for Pitches' Competition has now closed.

Partnering Meetings
Delegates will be able to attend pre-booked partnering meetings with investors to discuss potential collaborations.

The following investors will be attending BioCap this year:
Acceleris Capital, Alderley Park Ventures, Bamburgh Capital, Brightstart Partners, Capital Enterprise, Capital Cell, Catapult Ventures, Complete Resourcing, Deepbridge Capital LLP, Enterprise Ventures, Epidarex Capital, EV Group, Finance Wales plc, Foresight Group, GM&C Life Sciences Fund, Ignite Capital Partners, Innovate UK, IP Group, Johnson & Johnson Innovation, Kreos Capital, Laidlaw & Company, Liberum, Longbow Capital, London Stock Exchange, Maven, Mercia, Medius Associates, Nasdaq, New Wave Ventures, North West Business Angels, Northstar Ventures, Parkwalk Advisors, Peel Hunt, Pfizer LLC, Syncona Investment Management, Scottish Development International, Shore Capital, Silicon Valley Bank, Spark Impact, Syndicate Room, Synergy Health, Takeda Ventures, Takeda TAKcelerator, Torreya Partners, Touchstone Innovations, WG Partners LLP, Warwick Ventures, WGN.

Conference Programme

Time

Sessions

Speakers

08.30-09.00

Coffee & Registration

09.00-09.10

Conference Welcome

Chris Doherty, Alderley Park Site Director, Manchester Science Partnerships

09.10-09.40

Keynote Speaker

Mene Pangalos, Executive Vice President, IMED Biotech Unit & Global Business Development, AstraZeneca

09.40-10.40

The New World Order: Effect of Brexit and Trump on the Markets

Mark Fahy, Head of UK Small & Mid-Cap Companies, London Stock Exchange
Isabella Schidrich, Managing Director, Nasdaq
Laura Collister, Brexit Lead, BIA
Norman Molyneux, Chief Executive, Acceleris Capital
Sam Whitehouse, Chief Operating Officer, QuantuMDx Group

10.40-11.10

Company Showcases
Leading Companies speak about their journey and the lessons that they have learnt

Magnesium Elektron
Premaitha Health

11.10-11.40

Coffee, Networking & Exhibition

11.40-13.10

Company 'Pitches' Competition

Judges
Gareth King, Life Science Partner, Catapult Ventures
Simon Graindorge, Director Healthcare, IP Group
Ashish Patel, Investment Manager, Mercia
Melanie Goward, Investment Director, Maven
Claire Brown, Investment Manager, BioCity Group

Elbe Valley Medical
Filisia Interfaces
GlySK
HolistX
iQur
NeuDrive Ltd
Ockham Biotech
Pharma Krysto

13.10-14.10

Lunch, Networking & Exhibition

13.10-15.10

121 Partnering

Pre-bookable meetings with event delegate via online partnering platform

14.10-14.40

State of the Nation

Glenn Crocker, CEO, BioCity

14.40-15.10

Company Showcases
Leading Companies speak about their journey and the lessons that they have learnt

Shield Therapeutics
Skin BioTherapuetics

15.10-16.10

Venturing: What is happening Nationally and Internationally

Shaun Grady, VP Business Development Operations, AstraZeneca
Hitesh Thakrar, Partner, Syncona Investment Management
Nooman Haque, Managing Director Life Sciences & Healthcare, Silicon Valley Bank
Ian Oliver, Executive Director, Ernst & Young
Bernard Ross, Chief Executive, Sky Medical Technology

16.10-16.20

Results of Pitching Competition

16.20

Close

Delegate Fees
Premium Member: £125.00 + VAT
Member: £155.00 + VAT
Non-Member: £275.00 + VAT

To discuss the sponsorship and exhibition opportunities available at the conference, please contact Helen Williams at helen.williams@bionow.co.uk or on 07714 168020.

> Register here